Ribahep 200 Mg Capsule
$81 – $206
|Price Per Unit
|Add To Cart
Ribahep 200 Mg Capsule
Ribahep 200 Mg Capsuel is a medicine that acts against viruses. It treats hepatitis C, RSV infection and viral hemorrhagic fever.
Common side effects of this medicine include feeling tired, nausea, headache, muscle pains, fever, and an irritable mood. Some serious side effects include liver problems, red blood cell breakdown and allergic reactions.
Don’t take Ribahep 200 Mg Capsuel if you are taking didanosine, if you have liver failure, kidney disease or autoimmune hepatitis. Tell your doctor if you have or have ever had a mental illness, cancer, diabetes, sexual transmitted disease, sarcoidosis, gout, Gilbert’s syndrome, thyroid, eye, pancreas, or lung disease. You are advised to stop consumption of alcohol or breastfeeding during this treatment
Drug = Ribavirin
Strength = 200 Mg
Manufacturer = ZydusCadila
Take Ribahep 200 Mg Capsuel in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Ribahep 200 Mg Capsuel is to be taken with food.
Itching or rash
Difficulty in breathing
Muscle cramps and stiffness
Blood in urine and stools
Burning, dry and itchy eyes
Pregnancy:-Ribahep 200 Mg Capsuel is not recommended for use in pregnant women or in male partners of pregnant women.
Breast-feeding:- Ribahep 200 Mg Capsuel is not recommended for use in breastfeeding women unless absolutely necessary. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.
Pancreatitis:-Ribahep 200 Mg Capsuel should be used with caution in patients with a known history of pancreatitis due to the increased risk of worsening of the condition. Any unusual symptoms should be reported to the doctor on priority. Ribahep 200 Mg Capsuel medicine may be discontinued based on the clinical condition of the patient.
Ophthalmologic Disorders:-Ribahep 200 Mg Capsuel is used in combination with alpha interferons. Alpha interferons may cause increased ophthalmological side effects in patients with a known history of ophthalmologic disorders. Close monitoring of eye function is recommended during treatment with this combination. The therapy may be discontinued based on the clinical condition of the patient.